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Abstract
Viral-bacterial coinfections, such as with influenza A virus and Streptococcus pneumoniae
(S.p.), are known to cause severe pneumonia. It is well known that the host response has
an important role in disease. Interleukin-1β (IL-1β) is an important immune signaling cytokine responsible for inflammation and has been previously shown to contribute to disease
severity in numerous infections. Other studies in mice indicate that IL-1β levels are dramatically elevated during IAV-S.p. coinfection. However, the regulation of IL-1β during coinfection is unknown. Here, we report the NLRP3 inflammasome is the major inflammasome
regulating IL-1β activation during coinfection. Furthermore, elevated IL-1β mRNA expression is due to enhanced TLR2-MYD88 signaling, which increases the amount of pro-IL-1β
substrate for the inflammasome to process. Finally, NLRP3 and high IL-1β levels were associated with increased bacterial load in the brain. Our results show the NLRP3 inflammasome
is not protective during IAV-S.p. coinfection.

Introduction
Secondary bacterial infections during influenza A virus (IAV) infection contribute to disease
severity and mortality [1–3]. Streptococcus pneumoniae (S.p.) and Staphylococcus aureus (S.a.)
are the dominant pathogens associated with IAV coinfection [1–3]. The coinfection of IAV
and S.p. results in pneumonia due to multiple factors [4–8]. After IAV exposure, S.p. causes a
severe infection requiring only a low inoculum size compared to a single infection [9]. IAV
can also alter host immunological responses or lung homeostasis that can subsequently impede
bacterial clearance [8, 10–13]. IAV infection enhances bacterial growth by depleting or
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functionally altering alveolar macrophages [11, 12, 14, 15] and dysregulating neutrophils [16–
18]. These two pathogens further work in a synergistic manner to increase activation of innate
immune pattern recognition receptors (PRRs), which results in enhanced cytokine production
and inflammation [9, 19–21]. Because the immune response to coinfection plays an essential
function in the pathology of this disease, it is important that we have a better understanding of
the causes of inflammation.
Although inflammation is necessary to fight infections, dysregulated cytokine production
can have a detrimental impact on pathogen clearance and also lead to immunopathology. For
example, anti-inflammatory cytokines, such as IL-10, counteract excessive inflammation during IAV-S.p. coinfection [19, 21]. However, elevated IL-10 during secondary bacterial pneumonia impairs the immune response and results in increased bacterial burden [19]. Type I
interferons (IFN-α/β) have important protective functions against viral replication, yet they
increase bacterial burden by decreasing neutrophil responses needed to fight off bacterial pathogens [22–25]. IFN-γ production is also linked to impaired alveolar macrophage function and
bacterial burden after coinfection [11, 12, 14, 26–29]. Although specific cytokines play pathological roles during coinfection, the treatment of human patients with corticosteroids during
coinfection provides little benefit [30–34]. Thus, the specific roles of cytokines need to be
examined in greater detail.
The inflammasome is a multiprotein complex containing an activating PRR, such as the
NLR Family Pyrin Domain Containing 3 (NLRP3) protein, the adaptor protein apoptosisassociated speck-like protein containing a caspase recruitment domain (ASC) and the cysteine
protease caspase-1 [35]. NLRP3 senses damage associated molecular patterns (DAMPs) like
reactive oxygen species, and K+ and H+ fluxes resulting from cell damage caused by IAV or S.
p. infection [36–40]. Absent in melanoma 2 (AIM2) can also activate the inflammasome when
it recognizes S.p. DNA in the cytoplasm of host cells [39, 41]. Active caspase-1 in the inflammasome cleaves inactive pro-IL-1β and pro-IL-18 into their active forms and also triggers pyroptotic cell death [42–44]. Once activated, IL-1β and IL-18 leave the cell through pores and
induce inflammation [42–44]. Previous research has shown that IL-1 receptor deficient mice
(Il1r1-/-) are more susceptible to IAV-S.p. and IAV-S.a. coinfection [45, 46]. However, how IL1β is produced and regulated during IAV-S.p. coinfection is not known. In particular, although
NLRP3 and AIM2 have known roles during single infections with IAV and S.p., their importance during coinfection with these pathogens is not known [36–41].
To gain a better understanding of the regulatory pathways for the inflammasome and IL-1β
during IAV-S.p. coinfection, we investigated the role for the NLRP3 and AIM2 inflammasomes both in vitro and in vivo in mice. Our data demonstrate the NLRP3 inflammasome primarily activated during IAV-S.p. coinfection. Furthermore, enhanced TLR2-MYD88
mediated priming contributes to elevated IL-1β levels. Finally, deletion of NLRP3 was associated with decreased bacterial burden in peripheral tissues and quicker weight recovery from
coinfection. Whereas Myd88-/- mice had lower bacterial burden in some tissues and less
inflammation in the lung, but they were more susceptible to coinfection. Together, these
results illuminate the contribution of the TLR2-MYD88-NLRP3 signaling axis during IAV-S.
p. secondary bacterial infection.

Materials and methods
Ethics statement
All animal experiments were performed under MSU Animal Care and Use Committee
(IACUC) protocol 16.009 in accordance with IACUC guidelines, the AVMA Guidelines on
Euthanasia, NIH regulations (Guide for the Care and Use of Laboratory Animals), and the U.
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S. Animal Welfare Act of 1966. IACUC approval was obtained for the use of Ketamine and
Xylazine for anesthesia. CO2 asphyxiation followed by cervical dislocation was the approved
method for euthanasia. In addition to mice, embryonated chicken eggs (Charles River Labs)
were infected with IAV at 10 days old for production of virus stocks.

Mice
C57BL/6J, Nlrp3-/-, Myd88-/- and Aim2-/- mice were originally obtained from The Jackson Laboratory and then bred in-house at Missouri State University (MSU). All in vivo experiments
were performed under biosafety level 2 conditions at the Missouri State University Vivarium.
Ripk2-/-, Trif-/-, Mavs-/-, Casp1/11-/-, Asc-/-, Tlr7-/-, and Tlr2-/- knockout mice were housed at
St. Jude Children’s Research Hospital and have been reported previously [47–49].

Infectious agents
Mouse-adapted influenza A/PR/8/34 H1N1 virus (hereafter referred as PR8) stocks were propagated by allantoic inoculation of hen’s eggs with seed virus. Plaque assays were performed
using Madin-Darby canine kidney cells to confirm stock titer. Type 3 S.p. (ATCC 6303) was
used in our studies. Colony Forming Units (CFU) assays were performed to confirm bacterial
stock concentrations using brain heart infusion (BHI) agar.

Cell culture
Bone Marrow Derived Macrophages (BMDMs) were generated by harvesting bone marrow
from tibia and femurs from WT, or Ripk2-/-, Trif-/-, Mavs-/-, Nlrp3-/-, Myd88-/-, Aim2-/-, Casp1/
11-/-, Asc-/-, Tlr7-/-, and Tlr2-/- knockout mice, all on the C57BL/6J background. After bone
marrow harvesting, cells were differentiated in L929 conditioned medium for 5 days as previously described [50]. BMDMs were then counted and seeded at a density of 1x106 cells per
well in 12 well plates. The following day, BMDMs were infected as described below.

In vitro infection
BMDMs were washed 2X with phosphate buffered saline (PBS), and 200μl of RPMI was added
to each well. BMDMs were then mock infected, or single infected with either 10 MOI of PR8
or 1 MOI of S.p., or coinfected with 10 MOI of PR8 then 3 hours later 1 MOI of S.p. After an
additional hour, 200μl RPMI with 20% FBS was added to all wells. Cell lysates and supernatants were then collected at 6 h, 12 h or 24 h for analysis by western blot, qRT-PCR, and
ELISA.

In vivo infection
On day 0, mice were anesthetized by intraperitoneal injection with 80mg/kg Ketamine and
8mg/kg Xylazine diluted in PBS. Groups of 5–7 mice were infected with 125 PFU PR8 intranasally in a volume of 30μl PBS. Some of these groups were then mock infected and the others
coinfected on day 7 with 1000 CFU S.p. intranasally in a volume of 30μl of PBS [9, 51]. Additional groups of 5–7 mice were singly infected with 1000 CFU S.p. on day 7. At each time
point, mice were monitor at least daily for weight loss and mice were euthanized by CO2
asphyxiation followed by cervical dislocation when they achieved 30% weight loss or became
moribund. Alternatively, mice were euthanized on day 9 or day 12 to collect lungs, liver, spleen
and brain for examining lung pathology, cytokine levels by ELISA and flow cytometry, and for
titering CFUs and PFUs. Viral titers from lungs that were homogenized by passing through a
70μm cell strainer were analyzed by plaque assay using MDCK cells as previously reported
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[52]. Quantification of S.p. from lung, liver, spleen and brain homogenates (also generated by
passing through a 70μm cell strainer) was performed by making 10-fold serial dilutions of lung
homogenate and plating 50μl on BHI agar plates and incubating in a 37˚C incubator with 5%
CO2.

Histology
Lungs from coinfected mice collected on day 9 (2 d post-coinfection) or day 12 (5 d post- coinfection) were fixed in 10% neutral buffered formalin. Lungs were embedded in paraffin and
5μm sections stained with hematoxylin and eosin. Sections were examined and scored according to the scoring system in Table 1. Total lung pathology was the sum of all individual category scores for each animal. Histology slides were scored by Dr. Christopher Gilbert, a board
certified pathologist at Cox Medical Hospital in Springfield, Missouri.

Enzyme-linked immunosorbent assay
Cytokine levels in cell culture supernatants or whole lung homogenates were analyzed using
mouse Ready-SET-Go ELISA kits (eBioscience) for IL-1β (88–7013), IL-6 (88–7064), or TNFα (88–7324). Assays were performed using the manufacturer’s recommendations. Microtiter
plates were read at 450nm using a BioTek ELx800 microplate reader.

Immunoblotting
Lysates collected from in vitro infected BMDMs at different time points as described above (In
vitro infection scheme and collection) were subjected to SDS-PAGE and gels were electrophoretically transferred onto polyvinylidine difluoride membranes (PVDF). Protein expression
was examined using the following primary antibodies: anti-β-Actin and anti-IL-1β (D6A8,
D3H1Z; Cell signaling technologies) were used with anti-rabbit HRP secondary antibody
(Jackson Immuno Research, 111-035-144). Membranes were incubated in SuperSignal West
Femto Maximum Sensitivity Substrate (ThermoScientific, 34096) and bands were visualized
using an Azure Biosystems C300 imaging system.

Isolation of mRNA and real-time qPCR
Extraction of total mRNA was done using TRIZOL (Invitrogen). mRNA was then reversetranscribed into cDNA using a high capacity cDNA reverse transcription kit (Applied
Table 1. Lung histology scoring metric.
Scoring

Infiltrate of neutrophils

Infiltrate of lymphocytes

Airways

Architecture

0

No significant abnormality.

No significant abnormality.

unremarkable

intact architecture

1

Minimal / focal

Minimal / focal

plugging

focal breakdown

2

Mild patchy

Mild patchy

obliteration

severe breakdown

3

Mild fairly diffuse

Mild fairly diffuse

4

Patchy moderate

Patchy moderate

5

Moderate

Moderate

6

Marked infiltrate

Marked infiltrate

Alveolar fluid

YES (+1) / NO (0)

Necrosis

YES (+1) / NO (0)

Table 1 provides the scoring metric used to evaluate lung histology samples. The higher the number, the more severe the pathology. Total lung pathology was the
combined score for all categories for an animal.
https://doi.org/10.1371/journal.pone.0212236.t001

PLOS ONE | https://doi.org/10.1371/journal.pone.0212236 February 22, 2019

4 / 16

NLRP3 inflammasome during coinfection

Biosystems, 4368814). cDNA samples were analyzed by real-time quantitative PCR (RTqPCR) using DyNAmo HS SYBR Green qPCR Kits (Thermo Scientific, F410L) and relative
values normalized to β-actin control. The following primer pairs were used: β-Actin FW
5’- GGC TGT ATT CCC CTC CAT CG-3’, Rev 5’-CCA GTT GTT AAC AAT
GCC ATG T-3’. IL-1β FW 5’ GAC CTT CCA GGA TGA GGA CA -3’, Rev 5’
AGC TCA TAT GGG TCC GAC AG-3’, TNF-α FW 5’-CAT CTT CTC AAA ATT
CGA GTG ACA A- 3’, Rev 5’-TGG GAG TAG ACA AGG TAC AAC CC-3’, IL6 FW 5’- TCC AGT TGC CTT CTT GGG AC -3’, Rev 5’- GTA CTC CAG AAG
ACC AGA GG -3’.

Flow cytometry
Lungs from coinfected mice were collected on day 9 (2 d post-coinfection) and passed through
a 70μM cell strainer. Cells were isolated by centrifugation through a 35% percoll solution and
then stained with a 1:200 dilution of each antibody to determine which cell types express proIL-1β in the lung during coinfection. An initial surface stain was performed using anti-CD11b,
anti-CD11c, anti-Gr1, anti-CD3ε, and anti-CD19 (TONBO biosciences, clones M1/70, N418,
RB6-8C5, 145-2C11, 1D3). Then, cells were fixed with IC Fixation Buffer and permeabilized in
1x Permeabilization Buffer (eBioscience, 00-8222-49, 00-8333-56) followed by staining with
anti-IL-1β pro-form (eBioscience, clone NJTEN3). Cells were distinguished based on the following gating strategies: CD3ε—CD19- CD11b+ CD11c- Gr1- (macrophages), CD3ε—CD19CD11b+ CD11c+ Gr1- (Dendritic cells), CD3ε-CD19-CD11b+CD11c-Gr1+ (neutrophils and
inflammatory monocytes), CD3ε+CD19- (T cells), CD3ε -CD19+ (B cells), and lineage negative
cells were considered mainly epithelial cells.

Statistical analysis
Student’s t-test, one-way and two-way ANOVA with Tukey’s or Dunn’s post hoc analysis were
performed using PRISM 6 from Graphpad. For weight loss during in vivo experiments, twoway ANOVA with Dunnett’s post hoc analysis was performed using PRISM 6. In vivo survival
analysis was performed using the Wilcoxon test using PRISM6. A p value <0.05 was considered statistically significant. Data are graphed as the mean +/- the SEM.

Results
Cell types producing IL-1β during IAV and S.p. coinfection
To determine the mechanisms by which coinfection of IAV and S.p. affect the inflammasome
and IL-1β, we first examined cells from the lungs of coinfected mice to determine which cell
types produced IL-1β. We found that only CD3ε- CD19- CD11b+ CD11c- Gr1- (macrophages),
CD3ε- CD19- CD11b+ CD11c+ Gr1- (Dendritic cells), and CD3ε- CD19-CD11b+ CD11c- Gr1+
(neutrophils and inflammatory monocytes) produced pro-IL-1β on day 2 post-coinfection
(Fig 1A–1C). CD3ε+ CD19- (T cells), CD3ε- CD19+ (B cells), and lineage negative cells (mainly
epithelial cells) showed no expression of pro-IL-1β (Fig 1A–1C). Based on these results, we
elected to use bone marrow derived macrophages (BMDMs) to examine the signaling pathways responsible for IL-1β production in vitro. BMDMs were infected with influenza A/PR/8/
34 H1N1 (PR8) and S. pneumoniae ATCC 6303 type 3 strain (S.p.) either alone or 3 h apart.
After 24 h, significant increases in the levels of IL-1β, IL-6 and TNF-α were observed from
BMDMs coinfection with IAV and S.p. compared to untreated or single infected samples (Fig
1D–1F).

PLOS ONE | https://doi.org/10.1371/journal.pone.0212236 February 22, 2019

5 / 16

NLRP3 inflammasome during coinfection

Fig 1. Increased production of cytokines in vitro during coinfection. (A-C) IL-1β protein expression in cells from
lungs of coinfected mice was determined by flow cytometry. (D-F) Samples collected from WT BMDMS 24 hours
post-infection were examined by ELISA for IL-1β, TNF-α and IL-6. Data are pooled from 2–5 independent
experiments with n = 2–3 wells per experiment. One-way ANOVA using Tukey’s post hoc analysis was used for
statistical comparison (Mean +/- SEM). ns: not significant, p values: <0.01 (�� ), <0.001 (��� ).
https://doi.org/10.1371/journal.pone.0212236.g001

The NLRP3 inflammasome controls IL-1β activation during coinfection
We next examined inflammasome activation by generating BMDMs from WT mice or mice
deficient in inflammasome genes Asc-/-, Casp1/11-/-, Nlrp3-/- or Aim2-/-. Following coinfection,
Asc-/-, Casp1/11-/-, and Nlrp3-/- BMDMs had significantly decreased IL-1β levels compared to
WT cells (Fig 2A). However, BMDMs lacking AIM2 were not significantly different from WT
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Fig 2. Production of IL-1β during coinfection is NLRP3 and TLR2 dependent. (A, D, F) BMDMs from the indicated genotype of mice were infected
with a single pathogen or coinfected. Samples of culture supernatant were collected 24 h post-infection and the levels of IL-1β secreted were analyzed by
ELISA. (B, E) Protein levels of pro-IL-1β were measured using Western blot analysis from samples collected at 6 h, 12 h, or 24 h after the indicated
infection. Tubulin was used as a loading control (� indicates non-tubulin bands). (C) mRNA from BMDMs samples collected at 6 h, 12 h, or 24 h postinfection with the indicated pathogens were examined for IL-1β, IL-6, and TNF-α gene expression by qRT-PCR. mRNA was normalized relative to βActin. Data are pooled from 2–5 independent experiments using n = 2–3 wells per experiment. One-way ANOVA using Tukey’s post hoc analysis was
used for statistical comparison (Mean +/- SEM). p values: <0.05 (� ), <0.01 (�� ), <0.001 (��� ).
https://doi.org/10.1371/journal.pone.0212236.g002
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cells during coinfection (Fig 2A), and they had IL-1β levels that were enhanced during S.p.
infection alone (Fig 2A).
In addition, we examined pro-IL-1β expression to determine if increased signaling through
PRRs during coinfection enhances priming signals. WT BMDMs were again infected with PR8
and S.p. alone or coinfected 3 hours apart. In samples collected 6 h, 12 h or 24 h after initial
infection, we observed pro-IL-1β expression was enhanced during coinfection compared to
singly infected samples (Fig 2B and S1 Fig). Pro-IL-1β expression was due to enhanced IL-1β
mRNA (Fig 2C). In fact, mRNA levels of several cytokines were enhanced, including TNF-α,
and IL-6 mRNA, in coinfected cells compared to single infected cells (Fig 2C). Overall, coinfection enhances transcriptional activation of cytokine genes.
We next examined the signaling pathways upstream that would regulate gene expression.
During coinfection, the NOD2-RIPK2 pathway would respond to S.p. peptidoglycan fragment
muramyl di-peptide (MDP), the RIG-I-MAVS pathway would respond to IAV uncapped
RNA, and TLRs 2, 3, 7 and 9 would respond to their various ligands and activate TRIF or
MYD88. Because all of these PRR pathways can facilitate NF-κB activation and cytokine gene
expression through their adaptor proteins, we determined which pathways are involved in IL1β production during coinfection by infecting BMDMs derived from WT, Ripk2-/-, Trif-/-,
Myd88-/- or Mavs-/- mice. Intriguingly, Trif-/- BMDMs had higher IL-1β levels than WT
BMDMs, suggesting TRIF signaling may play a regulatory role during coinfection (Fig 2D).
Importantly, only coinfected Myd88-/- BMDMs had significantly reduced IL-1β compared to
coinfected WT BMDMs (Fig 2D and 2E and S2 Fig). Finally, we found that Tlr2-/- BMDMs
had significantly impaired IL-1β production during coinfection compared to WT cells (Fig
2F), demonstrating that a TLR-2-MYD88 signaling pathways primes pro-IL-1β during
coinfection.

Pathways regulating IL-1β and the inflammasome in vivo during
coinfection
Mice were infected with a non-lethal dose of 125 PFU of PR8 on day 0 and then mock infected
or coinfected with a non-lethal dose of 1000 CFU S.p. on day 7. Another group of mice were
singly infected with S.p. on day 7. Similar to infection in BMDMs, lungs from coinfected WT
mice showed increased production of IL-1β, TNF-α, and IL-6 compared to PR8 or S.p. single
infection of WT mice (Fig 3A–3C). Compared to WT coinfected mice, deficiency in either
Nlrp3-/- or Myd88-/- had significantly decreased levels of IL-1β, and Myd88-/- mice also had significantly lower TNF-α levels (Fig 3A–3C). Although Myd88-/- mice lost more weight during
single infection with PR8, there was no difference in mortality (Fig 3D and 3E), yet in the case
of S.p. single infection, significant mortality was seen (Fig 3F–3G). During coinfection,
Myd88-/- mice had higher weight loss and mortality than WT mice (Fig 3H–3I). Aim2-/- mice
displayed a similar weight loss and mortality to WT mice (Fig 3H–3I). Finally, although
Nlrp3-/- mice had similar mortality compared WT mice, their weight recovered earlier than
any other genotype of mice (Fig 3H–3I).

Less bacteria in peripheral organs in Nlrp3-/- mice is associated with
improved weight recovery
To understand the improved weight recovery seen in Nlrp3-/- mice and the increased susceptibility of Myd88-/-, we examined viral and bacterial titers during coinfection. By day 9 (2 days
post-coinfection), PR8 was cleared from the lungs of most mice, and there were no significant
differences in viral titers (Fig 4A). S.p. titers were high on day 9 (2 days post-coinfection).
However, there was a trend for Nlrp3-/- mice toward lower bacterial burden in the lungs, but
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Fig 3. Production of IL-1β in vivo is dependent on MYD88 and NLRP3. (A-C) Indicated cytokine levels were examined in whole lung
homogenates on day 9 post-PR8, day 2 post-S.p. or day 2 post-coinfection. (D-I). Weight loss and mortality in mice infected with PR8
alone, S.p. alone, or PR8-S.p. coinfection. (A-C) Data are representative of two experiments, n = 5–7 mice per group per experiment.
One-way ANOVA using Tukey’s post hoc analysis was used for statistical comparison (Mean +/- SEM). (D-I) Data are combined from
2–3 experiments, total n is indicated. Two-way ANOVA using Tukey’s post hoc analysis was used for statistical comparison for weight
loss (Mean +/- SEM) and Kaplan-Meier Survival Plot and LogRank Test for survival data. ns: not significant, p values: <0.05 (� ), <0.01
(�� ), <0.001 (��� ).
https://doi.org/10.1371/journal.pone.0212236.g003
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Fig 4. Pathogen titers and lung pathology in coinfected mice. (A-B) Viral and bacterial titers in whole lung homogenates of coinfected mice on day 9
(day 2 after coinfection). (C) Total Lung pathology scores from coinfected mice on day 9 (day 2 after coinfection). (D-F) Lung pathology scores from
coinfected mice on day 12 (day 5 after coinfection). (G) Lung histology images on day 12 (day 5 after coinfection). Original magnification is 400x (B,
indicates Bronchi; Arrow, indicates region of lymphocyte infiltration). (H-K) Bacterial titers in whole lung, Liver, brain and spleen homogenates of
coinfected mice on day 12 (day 5 after coinfection). Data are representative of one-two independent experiments, n = 5–9 mice per group per
experiment. One-way ANOVA using Tukey’s post hoc analysis was used for statistical comparison (Mean +/- SEM). ns: not significant, p values: <0.05
(� ), <0.01 (�� ), <0.001 (��� ).
https://doi.org/10.1371/journal.pone.0212236.g004
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this did not reach statistical significance compared to WT mice (p = 0.0957) (Fig 4B). Examination of lung pathology on day 9 showed that Myd88-/- mice had slightly reduced overall lung
pathology that approached significance (p = 0.0696) compared to WT mice (Fig 4C). This was
mainly due to reduced cellular infiltrates into the lung (data not shown). Because differences
in weight between WT, Myd88-/- and Nlrp3-/- mice did not occur until day 10 or later, we
examined lung pathology and pathogen loads in mice on day 12 (5 d post-coinfection). There
was improved overall lung pathology in Myd88-/- mice on day 12, particularly with respect to
airway inflammation and lymphocyte numbers (Fig 4D–4G), but this was independent of lung
bacterial numbers, as all genotypes of mice had similar lung bacterial loads on day 12 (Fig 4H).
Bacterial numbers in the liver were also similar between all genotypes of mice (Fig 4I). Intriguingly, S.p. numbers in the brain were lower in both Nlrp3-/- and Myd88-/- mice compared to
WT and Aim2-/- mice (Fig 4J). However, Myd88-/- mice and Aim2-/- mice had more bacteria in
the spleen than WT or Nlrp3-/- mice (Fig 4K). Thus, earlier weight recovery in Nlrp3-/- mice
was associated with lower bacterial burden in both brain and spleen compared to other genotypes of mice, but was independent of lung pathology.

Discussion
The invasion of bacteria like S.p. in IAV infected hosts is linked to increased death rates during
pandemic outbreaks, such as the 1918 “Spanish Flu”, where pneumococcus was found in samples collected from infected individuals [53–56]. Coinfections also occur during seasonal influenza epidemics to varying degrees [34, 57]. Previous reports show that pro-inflammatory
cytokines, such as TNF-α, IL-6, and type I IFN, increase during coinfection [21, 22]. IL-6 and
type I IFN display detrimental effects but TNF-α is protective during coinfection [21, 22].
Thus, an improved understanding of the role for various cytokines and immune cells during
coinfection is needed to understand this disease.
Some studies have examined IL1 receptor signaling during bacterial coinfection with IAV.
Bansal et al. recently reported that Il1r1-/- mice are more susceptible to IAV-S.p. coinfection
due to decreased alveolar macrophage numbers in Il1r1-/- mice [45]. However, Bansal et al.
also found that Casp1-/- mice had similar survival to WT mice during IAV-S.p. coinfection
[45]. This is in agreement with our findings where in Nlrp3-/- mice had similar survival to WT
mice (Fig 3I). However, these results suggest the inflammasome and IL-1β are not responsible
for alveolar macrophage survival or mouse survival, or that IL-1β and IL-1α play redundant
roles. Alternatively, Bansal et al. hypothesized an inflammasome independent mechanism for
producing IL-1β [45]. A second group, Robinson et al., reported that Il1r1-/- mice are more
susceptible to coinfection with IAV and a different bacteria, S.a., due to impaired Th17
responses [46]. However, there is a notable difference between our findings and those reported
for Il1r1-/- mice infected with IAV-S.a. IAV-S.a. coinfection reduces IL-1β levels temporarily
for the first 24 hours [46]. In our experiments, coinfection with IAV and S.p. only results in
enhanced IL-1β levels. In a subsequent study, Robinson et al. treated IAV-S.a. infected mice
with the NLRP3 inflammasome inhibitor MCC950 and found decreased S.a. numbers in the
lungs, but similar survival compared to WT mice [58]. Similar to this second report by Robinson et al. [58], we found that IAV-S.p. coinfected Nlrp3-/- mice have lower bacterial numbers,
but this was mainly in the brain and spleen, not the lung (Fig 4J and 4K).
Although these studies have contributed to our understanding of IL-1 signaling during
coinfection, how the inflammasome is activated during IAV-S.p. coinfection was not well
understood. Our findings demonstrate increased expression of pro-IL-1β during coinfection
with IAV and S.p. is dependent on the TLR2-MYD88 pathway. Furthermore, we demonstrate
that Nlrp3-/- mice or macrophages release less IL-1β than WT controls or Aim2-/- macrophages
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and mice. Because Nlrp3 deletion did not completely eliminate IL-1β production in vivo, other
inflammasomes or pathways must be involved in IL-1β production in vivo during IAV-S.p.
coinfection. One hypothesis is that a combination of NLRP3 and AIM2 contributes to inflammasome activation in vivo. Alternatively, other proteases in the lung, such as neutrophil elastase, may activate IL-1β [58]. Although Nlrp3-/- mice had only partially decreased IL-1β levels,
we did observe improved weight recovery in these mice compared to WT mice. However,
instead of reducing overt inflammation, as we originally hypothesized, Nlrp3-/- mice had similar inflammation to WT mice, in the lungs. Instead, on day 12, Nlrp3-/- mice had low bacterial
burden in both brain and spleen, which was not observed in any other genotype of mice. This
suggests the inflammasome and IL-1β may inhibit specific responses required for bacterial
control, as eliminating NLRP3 improves bacterial burden. However, the mechanisms involved
will require further investigation. As mentioned above, a previous report showed that mice
treated with the NLRP3 inflammasome inhibitor MCC950 had decreased S.a. numbers during
IAV coinfection, and this would support this hypothesis [58]. Interestingly, Myd88-/- mice in
our experiments displayed decreased levels of IL-1β in the lung, decreased bacteria in the
brain, and decreased lung pathology, yet they were more susceptible to coinfection. This
would suggest that overt inflammation and tissue damage are not the only factors involved
during coinfection [59].

Supporting information
S1 Fig. Original western blots for Fig 2B. All western blots in their uncropped format used to
make conclusions presented in Fig 2B for this paper are included here.
(TIF)
S2 Fig. Original western blots for Fig 2E. All western blots in their uncropped format used to
make conclusions presented in Fig 2E for this paper are included here.
(TIF)
S1 File. Supporting data for graphs. This file contains all the original data points used to generate the graphs throughout the manuscript.
(XLSX)
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